Back
Sage Therapeutics Stock Predictions
Sponsored
SAGE
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
SAGE
Sage Therapeutics
Last Price:
5.15
Seasonality Move:
13.05%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Sage Therapeutics Stock Forecast
- Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 6.2% based on the past 10 years of stock performance.
- Sage Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Sage Therapeutics Stock Undervalued?
The current Sage Therapeutics [SAGE] share price is $5.17. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal. - SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sage Therapeutics has on average historically fallen by 6.2% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
- Sage Therapeutics has fallen lower in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
28.26
52-Week Low:
4.62
Prediction Charts
Market Cap:
316.27M
Price in USD:
5.17
Volume:
870.85K
Beta:
1.36
Technical Analysis
SMA50:
6.71
SMA100:
8.11
SMA200:
11.95
52-Wk Change:
-73.39%
Stock Predictions
-
Is Sage Therapeutics stock public?
Yes, Sage Therapeutics is a publicly traded company. -
What is the Sage Therapeutics stock quote today?
The Sage Therapeutics stock price is 5.17 USD today. -
How to buy Sage Therapeutics stock online?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 5.67 | 5.94 | 5.95 | 5.64 |
Nov-6 | 6.27 | 5.95 | 6.44 | 5.93 |
Nov-7 | 5.96 | 6.32 | 6.42 | 5.86 |
Nov-8 | 6.33 | 6.31 | 6.39 | 6.17 |
Nov-11 | 6.46 | 6.31 | 6.65 | 6.29 |
Nov-12 | 6.23 | 5.73 | 6.28 | 5.73 |
Nov-13 | 5.71 | 5.74 | 5.86 | 5.63 |
Nov-14 | 5.87 | 5.37 | 5.87 | 5.34 |
Nov-15 | 5.44 | 5.10 | 5.44 | 5.03 |
Nov-18 | 5.06 | 4.78 | 5.09 | 4.74 |
Nov-19 | 4.74 | 4.91 | 4.95 | 4.70 |
Nov-20 | 4.75 | 4.91 | 5.13 | 4.62 |
Nov-21 | 5.02 | 4.85 | 5.19 | 4.80 |
Nov-22 | 4.85 | 5.17 | 5.21 | 4.85 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.